PharmaShots | Incisive News in 3 Shots

Subscribe Now

Immorna Biotherapeutics

Immorna Biotherapeutics Reports the US FDA’s IND Clearance to Commence P-I/II Trial of JCXH-211 IV for Solid Tumors

Immorna Biotherapeutics Reports the US FDA’s IND Clearance to Commence P-I/II Trial of JCXH-211 IV for Solid Tumors

July 8, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us